Company Name, Ticker, Customers, else..

Paratek Pharmaceuticals Inc (NASDAQ: PRTK)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Paratek Pharmaceuticals Inc 's

Name: Paratek Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PRTK Sales vs. its Competitors Q1 2023

Comparing the current results to its competitors, Paratek Pharmaceuticals Inc reported Revenue increase in the 1 quarter 2023 by 25.64 % year on year.
The revenue growth was below Paratek Pharmaceuticals Inc 's competitors' average revenue growth of 38.83 %, achieved in the same quarter.

• List of PRTK Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Paratek Pharmaceuticals Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< PRTK Stock Performance Comparisons

<< See the full list of PRTK competitors

Overall company Market Share Q1 2023

Contrary to strong revenue growth of 25.64 % in Overall company, Paratek Pharmaceuticals Inc has lost market share within this division. << More on PRTK Market Share.

*Market share is calculated based on total revenue.

PRTK's Stock Performance relative to its Competitors

Publicly Traded Peers of Paratek Pharmaceuticals Inc

Bioxcel Therapeutics Inc
Share Performance

-93.14%

This Year

Bioxcel Therapeutics Inc

Profile

BioXcel Therapeutics Inc. is a biopharmaceutical company that operates using an innovative business model. They utilize artificial intelligence (AI) and big data analytics to identify and develop novel therapies for targeted diseases with unmet medical needs. This approach allows them to leverage data-driven insights to expedite drug discovery and development, potentially increasing the efficiency and success rate of their drug candidates.

More about Bioxcel Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 3.533 mill.	$ 0.742 mill.	$ -70.860 mill.

Jaguar Health Inc
Share Performance

-98.76%

One Year

Jaguar Health Inc

Profile

Jaguar Health Inc's business model revolves around developing and commercializing natural, plant-based products for human and animal health. They aim to provide innovative solutions utilizing their scientific expertise in the development of novel medicines and consumer healthcare products.

More about Jaguar Health Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.591 mill.	$ 27.815 mill.	$ -36.920 mill.

Scynexis Inc
Share Performance

+2.11%

This Year

Scynexis Inc

Profile

Scynexis Inc's business model revolves around the development and commercialization of innovative and effective antifungal therapies.

More about Scynexis Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 61.722 mill.	$ 19.215 mill.	$ -10.235 mill.

Cidara Therapeutics Inc
Share Performance

+719.93%

One Year

Cidara Therapeutics Inc

Profile

Cidara Therapeutics Inc's business model revolves around developing novel therapeutics to address serious fungal and viral infections.

More about Cidara Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 5,951.218 mill.	$ - mill.	$ -148.416 mill.

Nabriva Therapeutics Plc
Share Performance

-29.00%

This Year

Nabriva Therapeutics Plc

Profile

Nabriva Therapeutics Plc's business model involves the development and commercialization of innovative antibiotics for the treatment of serious infections.

More about Nabriva Therapeutics Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4.588 mill.	$ 29.557 mill.	$ -55.054 mill.

1 more competitors available

Sources: Paratek Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 3, 2026 11:36 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Paratek Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.